- Home
- OM vs JLS Comparison
OM vs JLS Comparison
Compare OM & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OM | JLS |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.2M | 100.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | OM | JLS |
|---|---|---|
| Price | $5.20 | $18.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 26.6K |
| Earning Date | 02-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,069,000.00 | N/A |
| Revenue This Year | $6.23 | N/A |
| Revenue Next Year | $8.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.65 | N/A |
| 52 Week Low | $3.10 | $15.48 |
| 52 Week High | $21.98 | $17.97 |
Technical Indicators
Market Signals| Indicator | OM | JLS |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | 49.57 |
| Support Level | $4.97 | $18.06 |
| Resistance Level | $5.69 | $18.25 |
| Average True Range (ATR) | 0.52 | 0.12 |
| MACD | 0.29 | 0.04 |
| Stochastic Oscillator | 60.86 | 67.14 |
Price Performance
Historical ComparisonAbout OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.